Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.80% is 94% below its 5-year average of 28.44%, near the low end of its 5-year range (0.73%–88.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 83.16% above its 12-month average of 0.98%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.80%.
DEBT TO ASSETS RATIO
1.80%
DEBT TO ASSETS RATIO AVG TTM
0.98%
DEBT TO ASSETS RATIO AVG 3Y
11.63%
DEBT TO ASSETS RATIO AVG 5Y
28.44%
DEBT TO ASSETS RATIO AVG 10Y
25.43%
DEBT TO ASSETS RATIO AVG 15Y
13.29%
DEBT TO ASSETS RATIO AVG 20Y
7.52%
CURRENT VS TTM AVG
+83.16%
CURRENT VS 3Y AVG
-84.55%
CURRENT VS 5Y AVG
-93.68%
CURRENT VS 10Y AVG
-92.93%
CURRENT VS 15Y AVG
-86.47%
CURRENT VS 20Y AVG
-76.11%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 668 covered companies
CURRENT VS SECTOR MEDIAN
+1697.57%
vs the sector median at left
Delcath Systems, Inc.
Market Cap
$538.54M
Debt to Assets Ratio
1.80%
TTM Avg
0.98%
3Y Avg
11.63%
5Y Avg
28.44%
Market Cap
$536.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.31M
Debt to Assets Ratio
0.51%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$541.86M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$551.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556.18M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$520.18M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$560.00M
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $538.54M | 1.80% | 0.98% | 11.63% | 28.44% |
| Crescent Biopharma, Inc. (CBIO)vs › | $536.92M | 0.01% | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $535.31M | 0.51% | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $541.86M | 0.00% | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $551.43M | 0.00% | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $521.19M | 0.07% | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.18M | 0.19% | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $520.18M | 0.00% | N/A | N/A | N/A |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $516.53M | 0.02% | N/A | N/A | N/A |
Debt/Assets
1.8%
Debt/Equity
0.02
Current Ratio
9.83
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.80% |
| 2026-03-31 | 0.73% |
| 2025-12-31 | 0.76% |
| 2025-09-30 | 0.78% |
| 2025-06-30 | 0.85% |
| 2025-03-31 | 1.16% |
| 2024-12-31 | 1.36% |
| 2024-09-30 | 9.69% |
| 2024-06-30 | 16.46% |
| 2024-03-31 | 23.48% |
| 2023-12-31 | 26.38% |
| 2023-09-30 | 21.00% |
| 2023-06-30 | 46.81% |
| 2023-03-31 | 31.57% |
| 2022-12-31 | 88.87% |
| 2022-09-30 | 81.10% |
| 2022-06-30 | 77.98% |
| 2022-03-31 | 59.87% |
| 2021-12-31 | 49.07% |
| 2021-09-30 | 46.95% |
| 2021-06-30 | 10.64% |
| 2021-03-31 | 8.63% |
| 2020-12-31 | 8.50% |
| 2020-09-30 | 18.70% |
| 2020-06-30 | 12.35% |
| 2020-03-31 | 27.50% |
| 2019-12-31 | 20.13% |
| 2019-09-30 | 15.94% |
| 2019-06-30 | 217.51% |
| 2019-03-31 | 128.13% |
| 2018-12-31 | 29.78% |
| 2018-09-30 | 21.66% |
| 2018-06-30 | 7.56% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 67.21% |
| 2017-06-30 | 67.72% |
| 2017-03-31 | 29.93% |
| 2016-12-31 | 37.86% |
| 2016-09-30 | 17.34% |
| 2016-06-30 | 3.79% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-10-21 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
